Join to View Full Profile
14200 W Celebrate Life WayGoodyear, AZ 85338
Phone+1 623-207-3000
Are you Dr. Khemka?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Vivek Khemka, MD is an oncologist in Goodyear, Arizona. He is currently licensed to practice medicine in Arizona, California, and Washington.
Education & Training
Cooper Medical School of Rowan University/Cooper University HospitalFellowship, Hematology and Medical Oncology, 2005 - 2008
Zucker School of Medicine at Hofstra/NorthwellFellowship, Geriatric Medicine (Internal Medicine), 2003 - 2004
One Brooklyn Health System/Brookdale University Hospital and Medical CenterResidency, Internal Medicine, 2001 - 2003
Wyckoff Heights Medical CenterInternship, Internal Medicine, 2000 - 2001
Sri Ramachandra Medical CollegeClass of 1993
Certifications & Licensure
AZ State Medical License 2008 - 2026
CA State Medical License 2011 - 2026
NY State Medical License 2003 - 2026
NJ State Medical License 2005 - 2025
WA State Medical License 2011 - 2025
American Board of Internal Medicine Medical Oncology
National Board of Physicians and Surgeons Geriatric Medicine- National Board of Physicians and Surgeons Hospice and Palliative Medicine
- National Board of Physicians and Surgeons Internal Medicine
- National Board of Physicians and Surgeons Medical Oncology
Publications & Presentations
PubMed
- 4 citationsFirst-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial.Christian Marth, Richard G Moore, Mariusz Bidziński, Sandro Pignata, Ali Ayhan
Journal of Clinical Oncology. 2025-03-20 - 7 citationsCorrection to: Phase Ib/II study of gemcitabine, nab-paclitaxel, and pembrolizumab in metastatic pancreatic adenocarcinomaGlen J. Weiss, Lisa Blaydorn, Julia Beck, Kirsten Bornemann-Kolatzki, Howard B. Urnovitz
Investigational New Drugs. 2019-04-24 - 149 citationsPhase Ib/II study of gemcitabine, nab-paclitaxel, and pembrolizumab in metastatic pancreatic adenocarcinomaGlen J. Weiss, Lisa Blaydorn, Julia Beck, Kirsten Bornemann-Kolatzki, Howard B. Urnovitz
Investigational New Drugs. 2018-02-01
Press Mentions
CTCA at Western Regional Medical Center Advances Combination Immunotherapy Clinical TrialJanuary 8th, 2016
Clinical Trial Using Immunotherapy Drug Combinations to Treat Lung Cancer Appears SafeSeptember 9th, 2015
CTCA Initiates New Clinical Study of Immunotherapy Combined with ChemotherapyJuly 1st, 2015
